SENETEK hereby confirms that it has the expertise necessary to make use of any licensed patents and to develop, make, have made, sell, use, and otherwise commercially exploit the PRODUCTS.
SENETEK agrees to make reasonable efforts to make, have made, sell and otherwise commercially exploit the PRODUCTS, using similar efforts devoted to products of similar nature and similar markets.
SENETEK hereby confirms that it has the expertise necessary to make use of any licensed patents and to develop, make, have made, sell, use, and otherwise commercially exploit the PRODUCTS. Phloretamide
SENETEK hereby confirms that it has the expertise necessary to make use of any licensed patents and to develop, make, have made, sell, use, and otherwise commercially exploit the PRODUCTS. Plant Nucleic Acids
SENETEK agrees to make reasonable efforts to make, have made, sell and otherwise commercially exploit the PRODUCTS, using similar efforts devoted to products of similar nature and similar markets. Plant Nucleic Acids
SENETEK. POSTAL ADDRESS 000 Xxxxxxx Xxxx, Xxxx, XX 00000 STREET ADDRESS 000 Xxxxxxx Xxxx, Xxxx, XX 00000 XXXXXXXXX XX 0 000000 0000 XXXXXXXXX NO 0 000000 0000 CONTACT PERSON Andreas Xxxxxx XXXXXXX POSTAL ADDRESS XX Xxx 00000, Xxxxxxxx 8 XXXXXX XXXXXXX Xxxxxxx Xxxx Xxxxx, Xxxxxxx, Xxxxxxxx TELEPHONE NO 00649 835 0660 FACSIMILE NO 00000 000 0000 CONTACT PERSON Xxxxxxx Sierrnans DEVELOPMENT AND DISTRIBUTION AGREEMENT PRODUCT TRADE MARKS Invicorp 2 (1) InvicorpTM
SENETEK hereby confirms that it has the expertise necessary to make use of any licensed patents and to develop, make, have made, sell, use, and otherwise commercially exploit the PRODUCTS. Furfurylcytosine
SENETEK agrees to make reasonable efforts to commercially exploit the TREATMENT, using similar efforts devoted to products of similar nature and similar markets.
SENETEK. (i) Senetek represents and warrants that it is not in default of any term, provision or condition of the Basic Agreement/License and that its rights thereunder are not encumbered in any manner, and the Cell Line Products are free of any claims for infringement, patent or copyrights and trademarks of third parties. Senetek also represents and warrants that there is no litigation, claim or assessment pending or threatened against Senetek contesting Senetek's rights under the Basic Agreement/License. Senetek hereby indemnifies and will hold Signet harmless from any and all costs, expenses, claims, attorney's fees and so forth in regard to all matters which have transpired prior to the execution of this Agreement now known or hereafter arising from the Basic Agreement/License, including, but not limited to, any and all claims from RFMH.
